1. Home
  2. SNDX vs BRKL Comparison

SNDX vs BRKL Comparison

Compare SNDX & BRKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • BRKL
  • Stock Information
  • Founded
  • SNDX 2005
  • BRKL 1871
  • Country
  • SNDX United States
  • BRKL United States
  • Employees
  • SNDX N/A
  • BRKL N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • BRKL Savings Institutions
  • Sector
  • SNDX Health Care
  • BRKL Finance
  • Exchange
  • SNDX Nasdaq
  • BRKL Nasdaq
  • Market Cap
  • SNDX 1.2B
  • BRKL 1.0B
  • IPO Year
  • SNDX 2016
  • BRKL 1998
  • Fundamental
  • Price
  • SNDX $14.34
  • BRKL $12.43
  • Analyst Decision
  • SNDX Strong Buy
  • BRKL Buy
  • Analyst Count
  • SNDX 10
  • BRKL 3
  • Target Price
  • SNDX $36.20
  • BRKL $14.17
  • AVG Volume (30 Days)
  • SNDX 2.1M
  • BRKL 567.4K
  • Earning Date
  • SNDX 02-25-2025
  • BRKL 01-29-2025
  • Dividend Yield
  • SNDX N/A
  • BRKL 4.38%
  • EPS Growth
  • SNDX N/A
  • BRKL N/A
  • EPS
  • SNDX N/A
  • BRKL 0.77
  • Revenue
  • SNDX $16,000,000.00
  • BRKL $333,556,000.00
  • Revenue This Year
  • SNDX N/A
  • BRKL N/A
  • Revenue Next Year
  • SNDX N/A
  • BRKL $55.36
  • P/E Ratio
  • SNDX N/A
  • BRKL $16.01
  • Revenue Growth
  • SNDX N/A
  • BRKL 0.04
  • 52 Week Low
  • SNDX $12.06
  • BRKL $8.01
  • 52 Week High
  • SNDX $25.34
  • BRKL $13.15
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 54.69
  • BRKL 52.32
  • Support Level
  • SNDX $13.97
  • BRKL $11.54
  • Resistance Level
  • SNDX $13.16
  • BRKL $12.49
  • Average True Range (ATR)
  • SNDX 0.66
  • BRKL 0.31
  • MACD
  • SNDX 0.17
  • BRKL 0.05
  • Stochastic Oscillator
  • SNDX 85.39
  • BRKL 58.25

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About BRKL Brookline Bancorp Inc.

Brookline Bancorp Inc operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.

Share on Social Networks: